Literature DB >> 11532592

Opioids and the treatment of chronic pain in a primary care sample.

N J Adams1, M B Plane, M F Fleming, M P Mundt, L A Saunders, E A Stauffacher.   

Abstract

Chronic pain is a widespread, difficult problem facing clinicians. This study assessed the current medical management of a general population of patients with chronic pain in 12 family medicine practices located throughout the state of Wisconsin. Medical record audits were conducted on a sample of 209 adults. Sixty-seven percent were female with an average age of 53 years. The most common pain diagnoses included lumbar/low back (44%), joint disease/arthritis (33%), and headache/migraine (28%) pain. The most frequently prescribed opioids were oxycodone/acetaminophen (31%), morphine ERT (19%), Tylenol #3 (15%), and hydrocodone/acetaminophen (14%). Depression/affective disorders were reported in 36% of the patient charts, anxiety/panic disorders (15%), drug abuse (6%), and alcohol abuse (3%). Written drug contracts were utilized by 42% (n = 31) of the practitioners, pain scales 25% (n = 29), and urine toxicology screens 8% (n = 6). This study suggests that primary care practitioners have unique opportunities to identify and successfully treat patients with chronic pain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532592     DOI: 10.1016/s0885-3924(01)00320-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  31 in total

1.  Chronic pain and narcotics: a dilemma for primary care.

Authors:  Yngvild Olsen; Gail L Daumit
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

2.  Characteristics of older adults receiving opioids in primary care: treatment duration and outcomes.

Authors:  M Carrington Reid; Charles R Henderson; Maria Papaleontiou; Leslie Amanfo; Yelena Olkhovskaya; Alison A Moore; Sagar S Parikh; Barbara J Turner
Journal:  Pain Med       Date:  2010-07       Impact factor: 3.750

3.  Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain.

Authors:  Jane M Liebschutz; Richard Saitz; Roger D Weiss; Tali Averbuch; Sonia Schwartz; Ellen C Meltzer; Elizabeth Claggett-Borne; Howard Cabral; Jeffrey H Samet
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

Review 4.  Misuse of and dependence on opioids: study of chronic pain patients.

Authors:  Meldon Kahan; Anita Srivastava; Lynn Wilson; Douglas Gourlay; Deana Midmer
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

5.  Racial differences in primary care opioid risk reduction strategies.

Authors:  William C Becker; Joanna L Starrels; Moonseong Heo; Xuan Li; Mark G Weiner; Barbara J Turner
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

Review 6.  Informed consent in opioid therapy: a potential obligation and opportunity.

Authors:  Martin D Cheatle; Seddon R Savage
Journal:  J Pain Symptom Manage       Date:  2012-03-21       Impact factor: 3.612

7.  Primary care providers' views on chronic pain management among high-risk patients in safety net settings.

Authors:  Maya Vijayaraghavan; Joanne Penko; David Guzman; Christine Miaskowski; Margot B Kushel
Journal:  Pain Med       Date:  2012-07-30       Impact factor: 3.750

8.  Which skills are associated with residents' sense of preparedness to manage chronic pain?

Authors:  Aaron D Fox; Hillary V Kunins; Joanna L Starrels
Journal:  J Opioid Manag       Date:  2012 Sep-Oct

9.  Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study.

Authors:  Jennifer Brennan Braden; Ming-Yu Fan; Mark J Edlund; Bradley C Martin; Andrea DeVries; Mark D Sullivan
Journal:  J Pain       Date:  2008-07-26       Impact factor: 5.820

10.  Challenges in using opioids to treat pain in persons with substance use disorders.

Authors:  Seddon R Savage; Kenneth L Kirsh; Steven D Passik
Journal:  Addict Sci Clin Pract       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.